PMID: 2105909Feb 1, 1990Paper

Adrenergic receptors. Models for regulation of signal transduction processes

Hypertension
J R RaymondM G Caron

Abstract

Adrenergic receptors are prototypic models for the study of the relations between structure and function of G protein-coupled receptors. Each receptor is encoded by a distinct gene. These receptors are integral membrane proteins with several striking structural features. They consist of a single subunit containing seven stretches of 20-28 hydrophobic amino acids that represent potential membrane-spanning alpha-helixes. Many of these receptors share considerable amino acid sequence homology, particularly in the transmembrane domains. All of these macromolecules share other similarities that include one or more potential sites of extracellular N-linked glycosylation near the amino terminus and several potential sites of regulatory phosphorylation that are located intracellularly. By using a variety of techniques, it has been demonstrated that various regions of the receptor molecules are critical for different receptor functions. The seven transmembrane regions of the receptors appear to form a ligand-binding pocket. Cysteine residues in the extracellular domains may stabilize the ligand-binding pocket by participating in disulfide bonds. The cytoplasmic domains contain regions capable of interacting with G proteins and various k...Continue Reading

References

Sep 1, 1977·Life Sciences·S Berthelsen, W A Pettinger
Aug 1, 1990·Hypertension·M C MichelP A Insel
May 1, 1990·Trends in Pharmacological Sciences·R J LefkowitzM G Caron
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S CollinsR J Lefkowitz
Feb 1, 1989·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M C MichelO E Brodde
Sep 8, 1989·Science·L J EmorineA D Strosberg
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·T FrielleB K Kobilka
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J W ReganB K Kobilka
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S CotecchiaB K Kobilka
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J R Hadcock, C C Malbon
Jan 1, 1988·Annual Review of Cell Biology·J L BenovicR J Lefkowitz
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·T FrielleR J Lefkowitz
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J L BenovicR J Lefkowitz
Jan 1, 1987·Hypertension·W A Pettinger
May 15, 1987·The American Journal of Cardiology·A D Strosberg
Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·C D StraderR A Dixon
Aug 1, 1987·Canadian Journal of Physiology and Pharmacology·A D Baines
Oct 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·R R RuffoloJ P Hieble
Dec 22, 1988·Nature·J R BunzowO Civelli
Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·U WildenH Kühn

❮ Previous
Next ❯

Citations

Sep 1, 1992·Medicinal Research Reviews·P J van GalenK A Jacobson
Nov 1, 1990·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·P A JoseW Y Chan
Dec 1, 1993·Pharmacology & Therapeutics·O E Brodde
Sep 1, 1991·Brain Research. Molecular Brain Research·L YuH Lübbert
Oct 15, 1995·European Journal of Pharmacology·A J BalmforthS G Ball
Dec 4, 2002·European Journal of Pharmacology·Jaap OostendorpKnut Biber
Jan 24, 2002·Cancer Letters·Yasutsugu YamanakaHiroyuki Nakamura
Jan 1, 1996·Journal of Cardiovascular Pharmacology·P J ScarpaceN Tümer
Jul 27, 2001·Current Hypertension Reports·J de Champlain
Jul 1, 1996·Neurochemistry International·C A Colton, O N Chernyshev
Jan 1, 1993·Journal of Neurochemistry·R J Summers, L R McMartin
Nov 28, 2009·Vaccine·Marieke E HoonakkerCoenraad F M Hendriksen
Aug 1, 1991·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·S B Liggett
Oct 15, 2010·Chemical Biology & Drug Design·Bao-Min XiWen-Hua Chen
May 29, 1992·Biochemical and Biophysical Research Communications·M Q Ye, D P Healy
Jan 22, 1992·Biochemical Pharmacology·J R Jasper, P A Insel
Dec 1, 1994·Clinical and Experimental Pharmacology & Physiology·J F Marwood
Jan 1, 1994·Toxicologic Pathology·V E WhitehurstT Balazs
Mar 5, 2003·Pharmacological Reviews·Charles BrinkTakehiko Yokomizo
Apr 26, 2003·Journal of Hypertension·Ekaterina KintsurashviliHaralambos Gavras
Apr 17, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Ian C DavisSadis Matalon
May 15, 1991·Hospital Practice·C J Homcy
Jan 1, 1991·DNA Sequence : the Journal of DNA Sequencing and Mapping·S B Liggett, D A Schwinn
Oct 24, 2002·The Journal of Trauma·Satoki InoueHitoshi Furuya
Feb 1, 2009·Korean journal of anesthesiology·Seong Su KimIl Jung
Jan 1, 1992·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·D O QuissellF J Dowd
Aug 5, 1998·The American Journal of Physiology·U HoltbäckA Aperia
Oct 3, 1999·Physiological Reviews·A J Morris, C C Malbon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.